Opexa Therapeutics, Inc. (ACER) Lifted to “Hold” at ValuEngine
ValuEngine upgraded shares of Opexa Therapeutics, Inc. (NASDAQ:ACER) from a sell rating to a hold rating in a report released on Friday.
Opexa Therapeutics (NASDAQ ACER) opened at 9.92 on Friday. Opexa Therapeutics has a 12-month low of $0.96 and a 12-month high of $45.36. The company’s market capitalization is $7.33 million.
About Opexa Therapeutics
Acer Therapeutics Inc, formerly Opexa Therapeutics, Inc, is a pharmaceutical company. The Company is engaged in acquires, develops and intends to commercialize therapies for patients with serious rare diseases with critical unmet medical need. Its late-stage clinical pipeline includes Edsivo (celiprolol) and ACER-001.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Opexa Therapeutics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Opexa Therapeutics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.